Private sector tuberculosis care quality during the COVID-19 pandemic: a repeated cross-sectional standardised patients study of adherence to national TB guidelines in urban Nigeria
Authors:
- Angelina SassiASAngelina Sassi
- Lauren RosapepLRLauren Rosapep
- Bolanle Olusola FaleyeBFBolanle Olusola Faleye
- Elaine BaruwaEBElaine Baruwa
- Benjamin JohnsBJBenjamin Johns
- Abdullah Heel KafiAKAbdullah Heel Kafi
- Lavanya HuriaLHLavanya Huria
- Nathaly Aguilera VasquezNVNathaly Aguilera Vasquez
- Benjamin DanielsBDBenjamin Daniels
- Jishnu DasJDJishnu Das
- Chukwuma AnyaikeCAChukwuma Anyaike
- Obioma Chijioke-AkaniroOCObioma Chijioke-Akaniro
Open Access
- 14 November 2024
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 9 (11) , e015474
Abstract
Only a third of tuberculosis (TB) cases in Nigeria in 2020 were diagnosed and notified, in part due to low detection and under-reporting from the private health sector. Using a standardised patient (SP) survey approach, we assessed how management of presumptive TB in the private sector aligns with national guidelines and whether this differed from a study conducted before the start of the COVID-19 pandemic. 13 SPs presented a presumptive TB case to 511 private providers in urban areas of Lagos and Kano states in May and June 2021. Private provider case management was compared with national guidelines divided into three main steps: SP questioned about cough duration; sputum collection attempted for TB testing; and non-prescription of anti-TB medications, antibiotics and steroids. SP visits conducted in May–June 2021 were directly compared to SP visits conducted in the same areas in June–July 2019. Overall, 28% of interactions (145 of 511, 95% CI 24.5% to 32.5%) were correctly managed according to Nigerian guidelines, as few providers completed all three necessary steps. Providers in 71% of visits asked about cough duration (362 of 511, 95% CI 66.7% to 74.7%), 35% tested or recommended a sputum test (181 of 511, 95% CI 31.3% to 39.8%) and 79% avoided prescribing or dispensing unnecessary medications (406 of 511, 95% CI 75.6% to 82.8%). COVID-19 related questions were asked in only 2.4% (12 of 511, 95% CI 1.3% to 4.2%) of visits. During the COVID-19 pandemic, few providers completed all steps of the national guidelines. Providers performed better on individual steps, particularly asking about symptoms and avoiding prescription of harmful medications. Comparing visits conducted before and during the COVID-19 pandemic showed that COVID-19 did not significantly change the quality of TB care.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-022420)
- United States Agency for International Development (AID-OAA-A-15-00067)
This publication has 38 references indexed in Scilit:
- SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in NigeriaJAMA Network Open, 2022
- Simulated patients and their reality: An inquiry into theory and methodSocial Science & Medicine, 2022
- One year of COVID-19 and its impact on private provider engagement for TB: A rapid assessment of intermediary NGOs in seven high TB burden countriesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2021
- Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsPulmonology, 2021
- Addressing Africa’s pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan AfricaInternational Journal of Infectious Diseases, 2021
- TB and COVID – Public and private health sectors adapt to a new realityJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2020
- Quality of tuberculosis care in the private health sectorJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2020
- Africa's struggle with inadequate COVID-19 testingThe Lancet Microbe, 2020
- Lessons on the quality of tuberculosis diagnosis from standardized patients in China, India, Kenya, and South AfricaJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2019
- Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional studyThe Lancet Infectious Diseases, 2015